Dow Up 0.76% Nasdaq Up 0.69%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
4.39 Up 0.01(0.23%) Oct 24, 4:00PM EDT
|After Hours : 4.39 0.00 (0.00%) Oct 24, 7:18PM EDT
Prev Close:4.38
Open:4.40
Bid:N/A
Ask:4.65 x 300
1y Target Est:11.00
Beta:3.03
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.30 - 4.42
52wk Range:3.11 - 7.82
Volume:2,043,814
Avg Vol (3m):4,140,100
Market Cap:537.92M
P/E (ttm):N/A
EPS (ttm):-0.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OREX

Comparison

Symbol% ChgMkt Cap
OREXUp 0.23%537.92M
ABTUp 0.07%63.85B
GSKUp 0.95%109.99B
RHHBYDown 0.19%248.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):156.56
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.30
Quarterly EPS Est (Sep-14) :-0.03
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-1.01

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback